SCHEMBL14849198

SCHEMBL14849198

c1ccc(-c2cncc(-c3ccc4c5cccc6c(-c7cncc(-c8ccccc8)c7)ccc(c7cccc3c74)c65)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 5/20 0.43
▸ CYP11B2 P19099 4/20 0.43
▸ MKNK1 Q9BUB5 1/20 0.42
▸ MKNK2 Q9HBH9 1/20 0.42
▸ CHRNA7 P36544 1/20 0.41
▸ ATM Q13315 1/20 0.39
▸ MAP3K8 P41279 2/20 0.38
▸ KDR P35968 1/20 0.38
▸ SMO Q99835 1/20 0.38
▸ TNF P01375 1/20 0.38
▸ FDPS P14324 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ PIP4K2A P48426 1/20 0.36
▸ PIP4K2B P78356 1/20 0.36
▸ PIP4K2C Q8TBX8 1/20 0.36
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19825219 0.97 MAP3K8 (0.42) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL12345142 0.86 CYP11B1 (0.46) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL19825182 0.80 CYP11B1 (0.33) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL2448362 0.79 PARP1 (0.43) CYP11B1CYP11B2KDRTNF
SCHEMBL29444814 0.79 PARP1 (0.43) CYP11B1CYP11B2KDRTNF
SCHEMBL17242010 0.79 PARP1 (0.43) CYP11B1CYP11B2KDRTNF
SCHEMBL15446977 0.79 CYP11B1 (0.43) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL12345133 0.78 CYP11B1 (0.49) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL12076750 0.77 MKNK1 (0.57) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL722248 0.77 ATM (0.62) CYP11B1CYP11B2MKNK1MKNK2CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2500343-B1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME BEIJING VISIONOX TECHNOLOGY CO (CN) 2018-01-31 — — EP disclosed
US-9412951-B2 Organic materials and organic electroluminescent apparatuses using the same BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2016-08-09 — — US disclosed
US-9412951-B2 Organic materials and organic electroluminescent apparatuses using the same BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2016-08-09 — — US disclosed
US-20130087771-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME BEIJING VISIONOX TECHNOLOGY CO., LTD (CN) 2013-04-11 — — US disclosed
US-20130087771-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME BEIJING VISIONOX TECHNOLOGY CO., LTD (CN) 2013-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130087771-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME OR10J3, ORC3, OR51E2 CYP11B1 832/4885CYP11B2 624/4885MKNK1 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback